• SameOldJorts@lemmy.world
    link
    fedilink
    English
    arrow-up
    55
    ·
    1 year ago

    From the article: Henry Shelford, the CEO and a co-founder of ADHD UK, said: “ADHD is a disability and the sudden removal of medication is akin to removing a wheelchair from a disabled person that needs it.”

    Ok, but you’re still refusing to let another disabled person have a wheelchair in the first place so…

    • AceBonobo@lemmy.world
      link
      fedilink
      English
      arrow-up
      46
      ·
      edit-2
      1 year ago

      Are you saying the CEO of the charity organization, ADHD UK, is making the drug policy?

      • SameOldJorts@lemmy.world
        link
        fedilink
        English
        arrow-up
        8
        ·
        edit-2
        1 year ago

        No, (I get why you asked that, I should have worded my comment differently) it’s just funny to me this idea of fairness is to exclude those who haven’t yet been afforded the thing that would put them on more even footing with neurotypical individuals. I did read the article, I just am surprised that that’s how someone would say well let’s not help anyone that we’re not already helping, because fair’s fair. I also noticed it only seems to include 3 medications, so there are other options. I just kind of chuckled at the idea of no new wheelchairs angry face emoji

      • anlumo@lemmy.world
        link
        fedilink
        English
        arrow-up
        39
        ·
        1 year ago

        As far as I have followed this issue, this is a US problem. Pharmaceuticals are treated very differently in Europe. For example, there’s no public ads for prescription drugs allowed, meaning that patients usually don’t push doctors to prescribe random stuff they’ve heard about on TV.

          • ForgotAboutDre@lemmy.world
            link
            fedilink
            English
            arrow-up
            15
            ·
            1 year ago

            In the UK the NHS uses NICE guidelines for prescriptions. A doctor would be expected to justify prescribing outside of this.

            Additionally, ADHD charities report that it is under diagnosed in people in the UK. With many parents suspicious of medicating children.

              • AnyOldName3@lemmy.world
                link
                fedilink
                English
                arrow-up
                10
                ·
                1 year ago

                Unfortunately, that study was done a couple of hundred years after the UK lost control of North Carolina, so it doesn’t support the claim that ADHD medication is overprescribed in the UK.

                  • ForgotAboutDre@lemmy.world
                    link
                    fedilink
                    English
                    arrow-up
                    4
                    ·
                    1 year ago

                    Your quote doesn’t say they calculate the result globally. It’s estimated based on the results in Carolina. They say estimate because the don’t have the data to say it is true.

                    ADHD administrative prevalence (based on rates of diagnosis and/or prescriptions) in children and adolescents in the UK has been estimated to fall between 0.2 and 0.9% since the mid-2000s (39). These rates remain below community prevalence estimates in the UK estimated at around 2.2% in 1999 and 2005 (55, 56), with more recent estimates of 1.6% in 2017, based on the more restrictive ICD-10 Hyperkinetic Disorder criteria (57). Administrative prevalence of adult ADHD in the UK stands at around 0.1% (40), far below even some of the lowest prevalence rates documented in adults (9).

                    • Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus Statement, 2021

                    This suggests about 1% of the UK population has ADHD and isn’t diagnosed. The would be more than 600,000 people.

          • angrystego@lemmy.world
            link
            fedilink
            English
            arrow-up
            3
            ·
            1 year ago

            This used to be true and perhaps still is in some places, but in some European countries the laws have changed a bit recently which means bad time for pharma companies. They now don’t have enough finances to bribe doctors effectively. (Source: family member in European pharma.)

      • Heratiki@lemmy.ml
        link
        fedilink
        English
        arrow-up
        3
        ·
        1 year ago

        I had to jump through multiple hoops and complete a nearly perfect CAARS test before I could even get into contact with my psych. And then it was roughly a couple months talking with her before I was diagnosed. All in podunk USA. So it’s not rampant everywhere, especially since it’s nearly impossible to even find a psychiatrist within 150 miles of my house.